Results 291 to 300 of about 1,905,672 (358)

Risk prediction models for biochemical recurrence of Chinese prostate cancer patients after radical prostatectomy based on magnetic resonance imaging examination: a systematic review. [PDF]

Quant Imaging Med Surg
Wang Y, Shi Y, Wang L, Rong W, Du Y, Duan Y, Peng L.   +6 more
europepmc   +1 more source

Construction of a cuproptosis‑related lncRNA signature to predict biochemical recurrence of prostate cancer. [PDF]

Oncol Lett
Yu Z, Deng H, Chao H, Song Z, Zeng T.
europepmc   +1 more source

Impact of Cryopreserved Placental Allografts on Biochemical Recurrence in Prostate Cancer. [PDF]

Cancers (Basel)
Gottlieb J, Hanes DA, Bustos MA, Choe J, Luu A, Seizer D, Hoon DSB, Wilson TG.   +7 more
europepmc   +1 more source

The Association Between Lymphovascular or Perineural Invasion in Radical Prostatectomy Specimen and Biochemical Recurrence. [PDF]

Cancers (Basel)
Siech C, Wenzel M, Grosshans N, Cano Garcia C, Humke C, Koll FJ, Tian Z, Karakiewicz PI, Kluth LA, Chun FKH, Hoeh B, Mandel P.   +11 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

MRI and PSMA PET/CT of Biochemical Recurrence of Prostate Cancer.

Radiographics, 2023
Prostate cancer may recur several years after definitive treatment, such as prostatectomy or radiation therapy. A rise in serum prostate-specific antigen (PSA) level is the first sign of disease recurrence, and this is termed biochemical recurrence ...
M. Awiwi, M. Gjoni, Raghunandan Vikram, E. Altınmakas, Hakan Dogan, T. Bathala, Sagar Naik, Gregory C. Ravizzini, S. Kandemirli, K. Elsayes, U. Salem   +10 more
semanticscholar   +1 more source

PSMA PET/CT vs. CT alone in newly diagnosed biochemical recurrence of prostate cancer after radical prostatectomy: Comparison of detection rates and therapeutic implications.

European Journal of Radiology, 2021
OBJECTIVES To compare prostate specific membrane antigen (PSMA) Positron Emission Tomography/Computed Tomography (PET/CT) and computed tomography (CT) alone for the detection of biochemical recurrence of prostate cancer (PCa) and effect on treatment ...
J. Morawitz, J. Kirchner, J. Lakes, N. Bruckmann, E. Mamlins, A. Hiester, J. Aissa, C. Loberg, L. Schimmöller, C. Arsov, C. Antke, P. Albers, G. Antoch, L. Sawicki   +13 more
semanticscholar   +1 more source

Incorporating artificial intelligence in urology: Supervised machine learning algorithms demonstrate comparative advantage over nomograms in predicting biochemical recurrence after prostatectomy

The Prostate, 2021
After radical prostatectomy (RP), one‐third of patients will experience biochemical recurrence (BCR), which is associated with subsequent metastasis and cancer‐specific mortality.
Y. G. Tan, A. Fang, J. K. S. Lim, F. Khalid, Kenneth Chen, H. Ho, J. Yuen, H. Huang, K. Tay   +8 more
semanticscholar   +1 more source

Regional Lymph Node Metastasis on Prostate Specific Membrane Antigen Positron Emission Tomography Correlates with Decreased Biochemical Recurrence-Free and Therapy-Free Survival after Radical Prostatectomy: A Retrospective Single-Center Single-Arm Observational Study

Journal of Urology, 2021
Purpose: We sought to address the impact of preoperative prostate specific membrane antigen (PSMA) positron emission tomography (PET) findings prior to radical prostatectomy and pelvic lymph node dissection on biochemical recurrence and time to adjuvant ...
T. Amiel, C. Würnschimmel, M. Heck, T. Horn, N. Nguyen, L. Budäus, S. Knipper, M. Wenzel, I. Rauscher, M. Eiber, Hui Wang, T. Maurer   +11 more
semanticscholar   +1 more source

Prostate Cancer: Management of Biochemical Recurrence after Surgery

Archivos Españoles de Urología, 2023
Radical prostatectomy (RP) is one of the primary treatment options for localised prostate cancer (PCa). Despite its curative intent, 1/3 of patients will experience biochemical recurrence (BCR) during follow-up. Experts have devoted efforts to associate the influence of each individual factor with the risk of BCR to select the optimal treatment for ...
Elena, Moreno-Olmedo, Vladimir, Suárez-Gironzini, Juan Pablo, Fusco, Lucrecia, Ruiz, José, Begara, Marcos, Guijarro, Carmen, González San Segundo, Juan, Zafra, Fernando, López Campos, Felipe, Couñago   +9 more
openaire   +2 more sources

Salvage therapy at biochemical recurrence of prostate cancer

Nature Reviews Urology, 2020
No clear consensus exists for managing biochemically recurrent prostate cancer after prostatectomy. Interpretation of new data from the JCOG0401 trial warrants consideration of imaging techniques, prostate-specific antigen (PSA) levels at time of salvage radiotherapy (SRT), use of SRT ± salvage androgen deprivation therapy based on PSA levels, and the ...
Nicholas G. Zaorsky, Amar U. Kishan
openaire   +2 more sources